Interestingly, inhibition of Ataxia Telangiectasia Mutated (ATM) results in reversion of the EMT phenotype in cisplatin-resistant NSCLC cells, inhibiting cell invasion and tumor metastasis [72]. The gene discussed is ATM; the disease is non-small cell lung carcinoma.